Navigation Links
Patent Awarded for Miniature Chemical Detection Device
Date:3/11/2008

GOLDEN, Colo., March 11 /PRNewswire/ -- The U.S. Patent Office has awarded Dr. George Radziszewski a U.S. Patent (No. 7,342,664) for his revolutionary ChemiD Mini Lab, a miniature device that will identify chemical compounds on demand.

The ChemiD Mini Lab is designed to meet the critical need for an inexpensive, miniaturized analytical tool capable of rapidly and accurately detecting, identifying and monitoring the concentration of chemical substances.

The ChemiD Mini Lab is a novel configuration of a Fourier Transform Infrared (FTIR) spectrometer for spectrochemical analysis. FTIR is an instrument that can detect and decipher the molecular "fingerprint" of any chemical compound. Current FTIR technology is large, cumbersome and expensive.

"The ongoing hostilities in the Middle East and threats to homeland security underscore the need for an improved means of identifying explosives and toxic chemicals, so the market for such a device is enormous," according to Dr. Radziszewski, founder and CEO of ChemiD Research, LLC. He goes on to state, "our device could also contribute to improvements in energy efficiency, indoor/outdoor air quality and heighten the safety and security in millions of buildings worldwide." Similarly, the medical community "will benefit from a greatly enhanced potential for conducting non-invasive blood and bodily fluids sampling."

"Imagine every first responder and combat soldier with a handheld, chemical-detecting portable and automatic lab costing less than $500!" says Dr. Radziszewski. The patent culminates years of extensive research. The ChemiD Mini Lab will be the smallest, least expensive and most powerful device yet to be introduced. Capable of real-time detection and identification of explosives, chemicals, narcotics and other airborne contaminants, Dr. Radziszewski's patent is on its way to a huge commercial success!

Prototype testing will take several months followed by the development of commercial packaging before units will be available.

With his device, Dr. Radziszewski envisions contribution to an improved quality of life, as consumers are able to determine potentially hazardous chemicals in their food and environment or perform non-invasive blood lab work as easily as they use a watch to tell time or read a thermometer to determine the temperature.

ChemiD Research is a Limited Liability Company formed in 2004 in the State of Colorado. (http://www.chemid.com)

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=74463


'/>"/>
SOURCE ChemiD Research, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Court of Appeals Reverses Lower Court Decision in Favor of TriMed, Inc. Patent Infringement Case
2. Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award
3. Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims
4. Consumer Groups Will Continue to Press Stem Cell Patent Challenge
5. IDC receives patent on dual energy imaging technology
6. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
7. A device that measures optimum state of an organ prior to transplanting has been patented
8. CryoCath Provides Update on Patent Infringement Lawsuit
9. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
10. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
11. Carringtons DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 bottles ... AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while doing ... an over the counter heart healthy drink, can reduce Arterial Plaque, Lower Blood ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... growing as it continues developing an ANSI-approved, consensus-based American National Standard for ... plans to publish the first ANSI-approved GMP standard for dietary supplements this ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an ... 20, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , Home health and hospice companies are still popular targets for healthcare investors. ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Tuesday, March 28, ... American public to take the Diabetes Risk Test to find out if they are ... Angeles World Airports will light up the evening sky by programming the LAX pylons ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... , March 29, 2017  Spiral Therapeutics, ... agreement with Bionure Farma, S.L. for the worldwide ... to BN119 in the field of otolaryngology for ... sales-based royalties. The agreement provides Spiral with ... with a differentiated product profile. Under the terms ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology: